ACROPHOBIA TESTS OR FEAR OF HEIGHT DIAGNOSTIC TEST
Reading File
Finding Sources
Finding Sources
Reading File
Reading File
Reading File
Finding Sources
Finding Sources
Reading File
Here is a comprehensive clinical overview of acrophobia — its definition, diagnostic criteria, assessment tools, and management.
Acrophobia (Fear of Heights) — Diagnostic Overview
Definition
Acrophobia is the persistent, excessive dread of heights. It is classified as a Specific Phobia, Natural Environment type under both DSM-5 and ICD-10. The fear goes beyond the true threat of the stimulus and causes avoidance and functional impairment.
"Acrophobia: Dread of high places." — Kaplan and Sadock's Synopsis of Psychiatry
DSM-5 Diagnostic Criteria for Specific Phobia (Acrophobia)
Acrophobia meets diagnosis under Specific Phobia — Natural Environment subtype (DSM-5 code 300.29 / ICD-10 F40.228) when ALL of the following criteria are met:
| Criterion | Requirement |
|---|---|
| A | Marked fear or anxiety about a specific object or situation (e.g., heights) |
| B | The phobic object/situation almost always provokes immediate fear or anxiety |
| C | The phobic object/situation is actively avoided or endured with intense fear or anxiety |
| D | The fear/anxiety is out of proportion to the actual danger and to the sociocultural context |
| E | The fear, anxiety, or avoidance is persistent, typically lasting ≥ 6 months |
| F | Causes clinically significant distress or impairment in social, occupational, or other functioning |
| G | Not better explained by another mental disorder (agoraphobia, OCD, PTSD, separation anxiety, social anxiety disorder) |
In children, the fear or anxiety may be expressed by crying, tantrums, freezing, or clinging.
— Kaplan & Sadock's Comprehensive Textbook of Psychiatry, p. 5330
ICD-10 Classification
Under ICD-10, acrophobia falls under Specific (Isolated) Phobias — phobias restricted to highly specific situations, objects, or activities. Exposure causes panic. The natural environment subtype explicitly includes heights (alongside storms and water).
Key Diagnostic Features
| Feature | Description |
|---|---|
| Trigger | Exposure to heights (real or imagined) — tall buildings, ladders, bridges, open staircases, fire towers, balconies |
| Response | Immediate anxiety or panic, somatic symptoms (racing heart, nausea, sweating, dizziness) |
| Behavior | Active avoidance or painful endurance of height-related situations |
| Insight | Patients usually recognize the fear is irrational but cannot control it |
| Duration | Must persist ≥ 6 months |
| Impairment | Interferes with work (e.g., avoiding certain buildings or commutes) or daily life |
Differential Diagnosis
Acrophobia must be distinguished from:
- Agoraphobia — fear involves multiple situations (public transport, open spaces, crowds), not just heights
- Panic disorder — recurrent, unexpected panic attacks without a specific phobic stimulus
- OCD — avoidance tied to obsessive fears (e.g., fear of jumping), not the height itself
- PTSD — avoidance linked to a traumatic event involving heights
- Vertigo / vestibular disorders — a medical cause must be excluded
Assessment Tools Used in Clinical Research
While DSM-5 criteria form the formal diagnostic standard, several validated self-report and behavioral tests have been used in research and clinical settings for acrophobia:
| Tool | Description |
|---|---|
| Behavioral Avoidance Test (BAT) | Patient is asked to approach height-related situations (e.g., climbing floors of a building); behavioral avoidance and anxiety ratings are recorded |
| Acrophobia Questionnaire (AQ) | Self-report measure assessing anxiety and avoidance in 20 height-related situations |
| Attitudes Towards Heights Questionnaire (ATHQ) | Measures cognitive distortions and attitudes about heights |
| Subjective Units of Distress Scale (SUDS) | Patient rates distress 0–100 during exposure to heights |
| Virtual Reality Exposure Testing | Used in both diagnosis and treatment; virtual height environments are presented and anxiety responses are measured; validated in numerous RCTs for acrophobia |
"Beneficial effects have been reported with virtual reality exposure of patients with height phobia... Much experimental work is ongoing." — Kaplan and Sadock's Synopsis of Psychiatry
Treatment (Summary)
| Approach | Evidence |
|---|---|
| Exposure therapy (CBT) | First-line; graded exposure to height stimuli (systematic desensitization — e.g., climbing to increasingly higher floors while practicing relaxation) |
| Virtual Reality CBT | Strong evidence; self-guided VR CBT shown effective in RCTs (JAMA Psychiatry, 2019) |
| D-cycloserine (DCS) augmentation | NMDA partial agonist; used as adjunct to CBT; accelerates fear extinction in acrophobia |
| Benzodiazepines | Short-term symptom relief; not curative |
| Psychodynamic therapy | May be considered when behavioral treatment fails, especially when the phobia is linked to unresolved conflict or loss |
"Several studies have shown the efficacy of DCS as an adjunct to exposure therapy or CBT in patients with acrophobia." — Kaplan & Sadock's Comprehensive Textbook of Psychiatry
Clinical Coding
| System | Code | Label |
|---|---|---|
| DSM-5 | 300.29 | Specific Phobia, Natural Environment |
| ICD-10 | F40.228 | Specific Phobia, Natural Environment (heights, storms, water) |
Sources: Kaplan & Sadock's Comprehensive Textbook of Psychiatry | Kaplan and Sadock's Synopsis of Psychiatry | Fuster and Hurst's The Heart, 15th Edition
This is a shared conversation. Sign in to Orris to start your own chat.